Human astrocytes and microglia show augmented ingestion of synapses in Alzheimer's disease via MFG-E8

Makis Tzioras1, Michael J D Daniels1, Caitlin Davies1

  • 1UK Dementia Research Institute, the University of Edinburgh, Edinburgh EH8 9JZ, UK; Centre for Discovery Brain Sciences, the University of Edinburgh, Edinburgh EH8 9JZ, UK.

Cell Reports. Medicine
|August 31, 2023
PubMed

Insights

Alzheimer's disease (AD) brains show glial cells, including astrocytes and microglia, engulfing more synapses. This synapse ingestion is linked to amyloid plaques and APOE4, suggesting a therapeutic target for AD cognitive decline.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Pathology

Background:

  • Synapse loss is a hallmark of Alzheimer's disease (AD), correlating with cognitive decline.
  • While mouse models implicate microglia in synapse loss, direct human evidence of glial involvement in synapse removal in AD is lacking.

Purpose of the Study:

  • To investigate the role of human astrocytes and microglia in synapse removal in Alzheimer's disease.
  • To determine if amyloid-β plaques and APOE4 influence glial synapse engulfment.
  • To explore the mechanism behind glial synapse phagocytosis in AD.

Main Methods:

  • Analysis of synaptic protein content in human astrocytes and microglia from AD and control brains.
  • In vitro co-culture experiments with human glial cells and synapses from AD patients and controls.
  • Investigation of the role of MFG-E8 in glial synapse phagocytosis.

Main Results:

  • Human astrocytes and microglia in AD brains contain significantly more synaptic protein than in controls.
  • Proximity to amyloid-β plaques and the presence of the APOE4 gene exacerbate this synaptic protein accumulation.
  • Both human astrocytes and microglia phagocytose synapses from AD patients more readily than control synapses in culture.
  • Inhibition of MFG-E8 interactions reduced the engulfment of AD synapses by glial cells.

Conclusions:

  • Human glial cells, including astrocytes and microglia, actively engulf synapses in Alzheimer's disease.
  • This process is enhanced by amyloid-β plaques and the APOE4 risk gene.
  • The MFG-E8 opsonophagocytic pathway plays a role in AD-associated glial synapse ingestion, presenting a potential therapeutic target.

Related Concept Videos